Shin Kawamata studied physics at Faculty of Science of Kyoto University, Japan (1975-1981) and medicine at medical school of Kobe University, Japan (1984-1990).  He started his carrier as a medical doctor (hematology) and got PhD degree from Kyoto University (1998). He developed various human leukemia models in SCID mice in his post doctoral period at Systemix Co., Palo Alto USA and Stanford University (1998-2001).  Shin became group leader of Regenerative Medicine Research Unit and general manager of Cell Processing Facility in Foundation for Biomedical Research and Innovation (FBRI) (2002-2014) and Director of R&D Center for Cell Therapy of FBRI (2015).  His major research field is stem cell biology and hematopoietic cell differentiation.